{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:48:14Z","timestamp":1789465694077,"version":"build-2803163510"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Epidemiol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Leveraging the Manhattan Lupus Surveillance Program (MLSP), a population-based registry of cases of systemic lupus erythematosus (SLE) and related diseases, we investigated the proportion of SLE with concomitant rheumatic diseases, including Sj\u00f6gren\u2019s disease (SjD), antiphospholipid syndrome (APLS), and fibromyalgia (FM), as well as the prevalence of autoantibodies in SLE by sex and race\/ethnicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Prevalent SLE cases fulfilled one of three sets of classification criteria. Additional rheumatic diseases were defined using modified criteria based on data available in the MLSP: SjD (anti-SSA\/Ro positive and evidence of keratoconjunctivitis sicca and\/or xerostomia), APLS (antiphospholipid antibody positive and evidence of a blood clot), and FM (diagnosis in the chart).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>1,342 patients fulfilled SLE classification criteria. Of these, SjD was identified in 147 (11.0%, 95% CI 9.2\u201312.7%) patients with women and non-Latino Asian patients being the most highly represented. APLS was diagnosed in 119 (8.9%, 95% CI 7.3\u201310.5%) patients with the highest frequency in Latino patients. FM was present in 120 (8.9%, 95% CI 7.3\u201310.5) patients with non-Latino White and Latino patients having the highest frequency. Anti-dsDNA antibodies were most prevalent in non-Latino Asian, Black, and Latino patients while anti-Sm antibodies showed the highest proportion in non-Latino Black and Asian patients. Anti-SSA\/Ro and anti-SSB\/La antibodies were most prevalent in non-Latino Asian patients and least prevalent in non-Latino White patients. Men were more likely to be anti-Sm positive.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Data from the MLSP revealed differences among patients classified as SLE in the prevalence of concomitant rheumatic diseases and autoantibody profiles by sex and race\/ethnicity underscoring comorbidities associated with SLE.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fepid.2024.1334859","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T04:59:05Z","timestamp":1709701145000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence of concomitant rheumatologic diseases and autoantibody specificities among racial and ethnic groups in SLE patients"],"prefix":"10.3389","volume":"4","author":[{"given":"Brendan","family":"Denvir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Carlucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Corbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Buyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Michael","family":"Belmont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather T.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Askanase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan M.","family":"Bathon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Geraldino-Pardilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousaf","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Ginzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim","family":"Putterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil E.","family":"Barbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Helmick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Parton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Izmirly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1002\/art.40192","article-title":"The incidence and prevalence of systemic lupus erythematosus in New York county (Manhattan), New York: the Manhattan Lupus Surveillance Program","volume":"69","author":"Izmirly","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/ard.59.3.230","article-title":"Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus","volume":"59","author":"McDonagh","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1097\/RHU.0000000000001574","article-title":"Frequency of polyautoimmunity in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"28","author":"Ordo\u00f1ez-Ca\u00f1izares","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1093\/rheumatology\/kez562","article-title":"Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER registry","volume":"59","author":"Mena-V\u00e1zquez","year":"2020","journal-title":"Rheumatol (Oxford, England)"},{"key":"B5","first-page":"374","article-title":"Sjogren\u2019s syndrome in SLE: part I. The frequency of the clinical and subclinical features of sjogren\u2019s syndrome in patients with SLE","volume":"86","author":"Grennan","year":"1977","journal-title":"N Z Med J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1191\/096120398678920046","article-title":"Systemic lupus erythematosus VII: frequency and impact of secondary sj\u00f8gren\u2019s syndrome","volume":"7","author":"Nossent","year":"1998","journal-title":"Lupus"},{"key":"B7","first-page":"201","article-title":"Sj\u00f6gren\u2019s syndrome in systemic lupus erythematosus","volume":"17","author":"Andonopoulos","year":"1990","journal-title":"J Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/art.20093","article-title":"Sj\u00f6gren\u2019s syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary sj\u00f6gren\u2019s syndrome","volume":"50","author":"Manoussakis","year":"2004","journal-title":"Arthritis Rheum"},{"key":"B9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10067-007-0720-0","article-title":"Clinical and laboratory profiles of systemic lupus erythematosus associated with Sj\u00f6gren syndrome in China: a study of 542 patients","volume":"27","author":"Pan","year":"2008","journal-title":"Clin Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3899\/jrheum.090804","article-title":"Secondary Sjogren\u2019s syndrome in systemic lupus erythematosus defines a distinct disease subset","volume":"37","author":"Baer","year":"2010","journal-title":"J Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/RHU.0b013e31823ecbdf","article-title":"Systemic lupus erythematosus with Sj\u00f6gren syndrome compared to systemic lupus erythematosus alone: a meta-analysis","volume":"18","author":"Yao","year":"2012","journal-title":"J Clin Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/03009742.2017.1324909","article-title":"Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sj\u00f6gren\u2019s syndrome (secondary Sj\u00f6gren\u2019s syndrome) focusing on autoimmune rheumatic diseases","volume":"47","author":"Alani","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jaut.2016.10.004","article-title":"The antiphospholipid syndrome in patients with systemic lupus erythematosus","volume":"76","author":"Pons-Estel","year":"2017","journal-title":"J Autoimmun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"A277","DOI":"10.1016\/j.autrev.2009.12.008","article-title":"The geoepidemiology of systemic lupus erythematosus","volume":"9","author":"Borchers","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/archinte.164.1.77","article-title":"High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus","volume":"164","author":"Ruiz-Irastorza","year":"2004","journal-title":"Arch Intern Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1002\/art.21224","article-title":"Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups","volume":"52","author":"Mok","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/1756-185X.13320","article-title":"Differences in quality of life determinants according to the presence of fibromyalgia in middle-aged female patients with systemic lupus erythematosus: a multicenter, cross-sectional, single-ethnicity cohort","volume":"21","author":"Moon","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/rheumatology\/keac207","article-title":"Fibromyalgia, mood disorders, cognitive test results, cognitive symptoms and quality of life in systemic lupus erythematosus","volume":"62","author":"Raghunath","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.rbr.2014.08.004","article-title":"The association of fibromyalgia and systemic lupus erythematosus change the presentation and severity of both diseases?","volume":"55","author":"de Araujo","year":"2015","journal-title":"Rev Bras Reumatol"},{"key":"B20","first-page":"S40","article-title":"Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus","volume":"34","author":"Torrente-Segarra","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/art.1780370812","article-title":"The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus","volume":"37","author":"Middleton","year":"1994","journal-title":"Arthritis Rheum"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1191\/0961203304lu480oa","article-title":"Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus","volume":"13","author":"Valencia-Flores","year":"2004","journal-title":"Lupus"},{"key":"B23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1191\/0961203303lu330oa","article-title":"Systemic lupus erythematosus in three ethnic groups: XV. Prevalence and correlates of fibromyalgia","volume":"12","author":"Friedman","year":"2003","journal-title":"Lupus"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00296-014-2972-8","article-title":"Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity","volume":"34","author":"Haliloglu","year":"2014","journal-title":"Rheumatol Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3899\/jrheum.080212","article-title":"Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity","volume":"36","author":"Wolfe","year":"2009","journal-title":"J Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1136\/ard.2003.013417","article-title":"Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus","volume":"63","author":"Hoffman","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1002\/art.21414","article-title":"Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?","volume":"52","author":"To","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B28","doi-asserted-by":"publisher","first-page":"i67","DOI":"10.1093\/rheumatology\/kex200","article-title":"The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus","volume":"56","author":"Lewis","year":"2017","journal-title":"Rheumatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1177\/0961203313502571","article-title":"Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes","volume":"22","author":"Gonz\u00e1lez","year":"2013","journal-title":"Lupus"},{"key":"B30","first-page":"1773","article-title":"Increased frequencies of sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus","volume":"15","author":"Arnett","year":"1988","journal-title":"J Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1002\/art.34651","article-title":"Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members","volume":"64","author":"Bruner","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s10067-015-2941-y","article-title":"Clinical associations of anti-smith antibodies in PROFILE: a multi-ethnic lupus cohort","volume":"34","author":"Arroyo-\u00e1vila","year":"2015","journal-title":"Clin Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/0961203316645204","article-title":"A study of the influence of ethnicity on serology and clinical features in lupus","volume":"26","author":"Morais","year":"2016","journal-title":"Lupus"},{"key":"B34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1191\/0961203302lu161oa","article-title":"Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the Southeastern United States","volume":"11","author":"Cooper","year":"2002","journal-title":"Lupus"},{"key":"B35","first-page":"153","article-title":"Characterization of a Portuguese population with systemic lupus erytematosus","volume":"32","author":"Santos","year":"2007","journal-title":"Acta Reumatol Port"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1177\/0961203316637431","article-title":"The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus","volume":"25","author":"Taraborelli","year":"2016","journal-title":"Lupus"},{"key":"B37","first-page":"344","article-title":"Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European concerted action on the immunogenetics of SLE","volume":"28","author":"Sebastiani","year":"1999","journal-title":"Scand J Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/art.37795","article-title":"Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with medicaid coverage, 2000\u20132004","volume":"65","author":"Feldman","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000614","article-title":"Incidence rates of systemic lupus erythematosus in the USA: estimates from a meta-analysis of the Centers for Disease Control and Prevention national lupus registries","volume":"8","author":"Izmirly","year":"2021","journal-title":"Lupus Sci Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/acr.23707","article-title":"The incidence and prevalence of adult primary Sjogren\u2019s syndrome in New York county","volume":"71","author":"Izmirly","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e000344-e","DOI":"10.1136\/lupus-2019-000344","article-title":"Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program","volume":"6","author":"Izmirly","year":"2019","journal-title":"Lupus Sci Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1093\/rheumatology\/keac703","article-title":"Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program","volume":"62","author":"Hasan","year":"2023","journal-title":"Rheumatol (Oxford)"},{"key":"B43","year":""},{"key":"B44","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/acr.24960","article-title":"Evaluation of the EULAR\/American College of Rheumatology classification criteria for systemic lupus erythematosus in a population-based registry","volume":"75","author":"Guttmann","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/acr.24508","article-title":"Venous thromboembolic events in African American lupus patients in association with antiphospholipid antibodies compared to white patients","volume":"74","author":"Gkrouzman","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11641","article-title":"Clinical and serologic phenotyping and damage indices in patients with systemic lupus erythematosus with and without fibromyalgia","author":"Corbitt","year":"2024","journal-title":"ACR Open Rheumatol"},{"key":"B50","first-page":"2145","article-title":"Fibromyalgia is a major contributor to quality of life in lupus","volume":"24","author":"Gladman","year":"1997","journal-title":"J Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/art.30187","article-title":"Network analysis of associations between serum interferon-alpha activity, autoantibodies, and clinical features in systemic lupus erythematosus","volume":"63","author":"Weckerle","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B52","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/art.42404","article-title":"Gene expression and autoantibody analysis revealing distinct ancestry-specific profiles associated with response to rituximab in refractory systemic lupus erythematosus","volume":"75","author":"Carter","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140380","article-title":"Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus","volume":"5","author":"Catalina","year":"2020","journal-title":"JCI Insight"},{"key":"B54","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3899\/jrheum.111061","article-title":"Differences between male and female systemic lupus erythematosus in a multiethnic population","volume":"39","author":"Tan","year":"2012","journal-title":"J Rheumatol"}],"container-title":["Frontiers in Epidemiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fepid.2024.1334859\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T04:59:12Z","timestamp":1709701152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fepid.2024.1334859\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":54,"alternative-id":["10.3389\/fepid.2024.1334859"],"URL":"https:\/\/doi.org\/10.3389\/fepid.2024.1334859","relation":{},"ISSN":["2674-1199"],"issn-type":[{"value":"2674-1199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"article-number":"1334859"}}